Latest News and Press Releases
Want to stay updated on the latest news?
-
BEIJING, Feb. 7, 2013 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
-
BEIJING, Jan. 29, 2013 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company") announced today that it will reconvene the extraordinary general meeting of...
-
BEIJING, Jan. 15, 2013 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company") announced today that it has adjourned its extraordinary general meeting of...
-
BEIJING, Jan. 14, 2013 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company") announced today that it intends to adjourn its extraordinary general meeting...
-
BEIJING, Dec. 14, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
-
3Q12 Revenue was RMB75.4 Million ($12.0 Million) 3Q12 Net Income was RMB2.5 Million ($0.4 Million) 3Q12 Non-GAAP Adjusted Net Income was RMB11.6 Million ($1.8 Million) Live conference call to...
-
BEIJING, Nov. 5, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
-
China Nuokang Bio-Pharmaceutical Inc. Enters Into Definitive Agreement for Going Private Transaction
BEIJING, Sept. 27, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
-
2Q12 Revenue was RMB72.9 Million ($11.5 Million) 2Q12 Net Income was RMB10.5 Million ($1.7 Million) 2Q12 Non-GAAP Adjusted Net Income was RMB11.3 Million ($1.8 Million) Live conference call to...
-
BEIJING, Aug. 1, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...